Surmodics reported $57.59M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Align Technology ALGN:US USD 2.5B 123.78M
Anika Therapeutics ANIK:US USD 167.76M 95K
Arrowhead Research ARWR:US USD 405.3M 27.09M
Baxter International BAX:US USD 7.81B 72M
Bioscrip BIOS:US USD 951.96M 74.82M
Cryolife CRY:US USD 237.99M 2.44M
Edap Tms EDAP:US EUR 70.85M 4.29M
Edwards Lifesciences EW:US USD 3.51B 250.8M
Haemonetics HAE:US USD 715.79M 28.01M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Merit Medical Systems MMSI:US USD 499.86M 7.23M
Mesa Laboratories MLAB:US USD 116.26M 11.87M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Stryker SYK:US USD 9.32B 493M
Surmodics SRDX:US USD 57.59M 2.45M